Gagnon Advisors, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Gagnon Advisors, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,532,555
-23.4%
180,3310.0%4.63%
-4.3%
Q2 2023$7,225,863
-1.8%
180,3310.0%4.84%
-2.1%
Q1 2023$7,359,308
+5.7%
180,3310.0%4.94%
+5.1%
Q4 2022$6,962,579
-27.4%
180,3310.0%4.70%
-24.3%
Q3 2022$9,592,000
-30.1%
180,331
-23.4%
6.21%
-25.3%
Q2 2022$13,726,000
-28.4%
235,445
-6.2%
8.31%
-5.8%
Q1 2022$19,167,000
+26.8%
251,1400.0%8.83%
+47.1%
Q4 2021$15,111,000
+12.4%
251,140
+4.6%
6.00%
+12.5%
Q3 2021$13,448,000
+3.9%
240,142
+12.6%
5.33%
+8.5%
Q2 2021$12,938,000
-4.8%
213,217
+10.0%
4.92%
-12.1%
Q1 2021$13,588,000
+17.1%
193,8600.0%5.59%
+7.3%
Q4 2020$11,601,000
-0.5%
193,8600.0%5.22%
-27.1%
Q3 2020$11,655,000
+14.6%
193,8600.0%7.15%
-2.3%
Q2 2020$10,172,000
+56.5%
193,8600.0%7.32%
+20.7%
Q1 2020$6,500,000
-26.0%
193,8600.0%6.06%
+23.2%
Q4 2019$8,782,000
+19.0%
193,8600.0%4.92%
+7.6%
Q3 2019$7,380,000
+58.0%
193,860
+80.5%
4.58%
+71.6%
Q2 2019$4,671,000107,4122.67%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders